A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : SD / solid dispersion

[Related PubMed/MEDLINE]
Total Number of Papers: 240
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   SD  (>> Co-occurring Abbreviation)
Long Form:   solid dispersion
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A Retrospective Biopharmaceutical Analysis of >800 Approved Oral Drug Products: Are Drug Properties of Solid Dispersions and Lipid-Based Formulations Distinctive? LBF
2020 Albendazole solid dispersions prepared using PEG6000 and Poloxamer188: formulation, characterization and invivo evaluation. ABZ, AUCs, FTIR, PEG 6000, PXRD, SEM
2020 Benznidazole/Poloxamer 407 Solid Dispersion as a New Strategy to Improve the Treatment of Experimental Trypanosoma cruzi Infection. CF
2020 Calcitriol tablets with hybrid lipid-based solid dispersions with enhanced stability and content uniformity. HLC
2020 Clarification of the Dissolution Mechanism of an Indomethacin/Saccharin/Polyvinylpyrrolidone Ternary Solid Dispersion by NMR Spectroscopy. IMC, PVP, SAC
2020 Development of binary dispersions and nanocomposites of irbesartan with enhanced antihypertensive activity. DSC, FE-SEM, FTIR, IBS, NC, SEM, TEM, XRD
2020 Evaluation of the Solid Dispersion System Engineered from Mesoporous Silica and Polymers for the Poorly Water Soluble Drug Indomethacin: In Vitro and In Vivo. DSC, FESEM, HPMC, IMC, IR, MSNs, PAMPA, PIs, PXRD
2020 Formulation strategy of nitrofurantoin: co-crystal or solid dispersion? ATR-FTIR, DSC, HPMC, NF
2020 Improvement in the Oral Bioavailability and Efficacy of New Ezetimibe Formulations-Comparative Study of a Solid Dispersion and Different Micellar Systems. DSC, EZ, EZ-RM, MS, PXRD, SEM
10  2020 Manufacturing strategies to develop amorphous solid dispersions: An overview. ---
11  2020 Oral Bioavailability Enhancement and Anti-Fatigue Assessment of the Andrographolide Loaded Solid Dispersion. AG
12  2020 Preparation and Characterization of Griseofulvin Solid Dispersions. GSV, IR, PM, PVP
13  2020 Preparation and evaluation of a novel solid dispersion using leucine as carrier. Leu, OA
14  2020 Preparation of Hot-Melt Extruded Dosage Form for Enhancing Drugs Absorption Based on Computational Simulation. API, HME, PBPK, PSA
15  2020 Solid Dispersion Pellets: An Efficient Pharmaceutical Approach to Enrich the Solubility and Dissolution Rate of Deferasirox. DFX, DSC, FTIR, PEG 4000, SEM, XRD
16  2020 Solubilization of phloretin via steviol glycoside-based solid dispersion and micelles. MC, PT, SA, STE
17  2020 Spray dried solid dispersion of repaglinide using hypromellose acetate succinate: invitro and invivo characterization. HPMCAS, SDSD
18  2020 The Effect of Cooling on the Degree of Crystallinity, Solid-State Properties, and Dissolution Rate of Multi-Component Hot-Melt Extruded Solid Dispersions. DSC, INM, PL-S630, XRPD
19  2019 Amorphous multi-system of celecoxib improves its anti-inflammatory activity in vitro and oral absorption in rats. BA, CXB, DW, SLS
20  2019 Comparison of paclitaxel solid dispersion and polymeric micelles for improved oral bioavailability and in vitro anti-cancer effects. BA, MDCK line, PTX, TPGS
21  2019 Cooperative effect of polyvinylpyrrolidone and HPMC E5 on dissolution and bioavailability of nimodipine solid dispersions and tablets. FB-T, NMP, PVP
22  2019 Design of Coenzyme Q10 solid dispersion for improved solubilization and stability. CQ10
23  2019 Development of a Ternary Solid Dispersion Formulation of LW6 to Improve the In Vivo Activity as a BCRP Inhibitor: Preparation and In Vitro/In Vivo Characterization. BCRP, DSC, FTIR, SEM, XRPD
24  2019 Development of solid dispersion lipid nanoparticles for improving skin delivery. CUR, SD-SLNs, SLNs
25  2019 Drug-polymer miscibility, interactions, and precipitation inhibition studies for the development of amorphous solid dispersions for the poorly soluble anticancer drug flutamide. FLT, MDSC, PM, PXRD
26  2019 Effect of Carrier Lipophilicity and Preparation Method on the Properties of Andrographolide⁻Solid Dispersion. AG, PEG, Tm
27  2019 Formulation of aripiprazole-loaded pH-modulated solid dispersions via hot-melt extrusion technology: In vitro and in vivo studies. ARI, DSC, HME, SA, SEM, XRD
28  2019 Highly Water-Soluble Solid Dispersions of Honokiol: Preparation, Solubility, and Bioavailability Studies and Anti-Tumor Activity Evaluation. AGJ, AIJ, HK, PLX
29  2019 Improvement of the dissolution rate and bioavailability of fenofibrate by the supercritical anti-solvent process. AUC, CSE, SAS
30  2019 Improving solubility and dissolution of meloxicam by solid dispersion using hydroxypropyl methylcellulose 2910 3 cps and nicotinamide. DTA, HPMC, MLX, NC, PXRD, SEM
31  2019 Insight into the Dissolution Molecular Mechanism of Ternary Solid Dispersions by Combined Experiments and Molecular Simulations. DSC, GLI, IR, MD, SEM, XRD
32  2019 Naftopidil-fumaric acid interaction in a solid dispersion system: Improving the dissolution rate and oral absorption of naftopidil in rats. NAF
33  2019 Predicting physical stability of solid dispersions by machine learning techniques. ED, RF
34  2019 Preparation of Liquid Oral Mucoadhesive Gastro-retentive System of Nimodipine. ---
35  2019 Preparation, characterization and ex vivo-in vivo assessment of candesartan cilexetil nanocrystals via solid dispersion technique using an alkaline esterase activator carrier. CC
36  2019 Preparation, physicochemical and pharmacological study of curcumin solid dispersion with an arabinogalactan complexation agent. AG, CUR, GPC
37  2019 Solid Dispersion of Kaempferol: Formulation Development, Characterization, and Oral Bioavailability Assessment. AUC, DSC, FTIR, KPF, SEM, XRD
38  2019 Solubility and bioavailability enhancement study of lopinavir solid dispersion matrixed with a polymeric surfactant - Soluplus. H-bond, HME, LPV, P-gp
39  2019 T2 Relaxation Study to Evaluate the Crystalline State of Indomethacin Containing Solid Dispersions Using Time-Domain NMR. APIs, IMC, PM, PVP, TD-NMR
40  2019 Ternary solid dispersion to improve solubility and dissolution of meloxicam. HPMC, MLX, NA
41  2018 Application of scCO2 technology for preparing CoQ10 solid dispersion and SFC-MS/MS for analyzing in vivo bioavailability. DSC, PXRD, SEM
42  2018 Association of Silver Nanoparticles and Curcumin Solid Dispersion: Antimicrobial and Antioxidant Properties. CUR
43  2018 Crystalline Ethylene Oxide and Propylene Oxide Triblock Copolymer Solid Dispersion Enhance Solubility, Stability and Promoting Time- Controllable Release of Curcumin. CUR, HPMC K4M, PVP-K30
44  2018 Dissolution and oral bioavailability enhancement of praziquantel by solid dispersions. AUCs, FTIR, PZQ, SDS, XRD
45  2018 Early formulation development of CKD-519, a new CETP inhibitor, for phase 1 clinical study based on in vitro and in vivo evaluation. CETP, SMEDDS
46  2018 Encapsulation of Solid Dispersion in Solid Lipid Particles for Dissolution Enhancement of Poorly Water-Soluble Drug. SDSLs, SLs
47  2018 Enhanced delivery of fixed-dose combination of synergistic antichagasic agents posaconazole-benznidazole based on amorphous solid dispersions. ASDs, AUC, BNZ, PCZ
48  2018 Enhancement of Aqueous Solubility and Dissolution of Celecoxib through Phosphatidylcholine-Based Dispersion Systems Solidified with Adsorbent Carriers. CLC, FT-IR, PC
49  2018 Enhancement of lymphatic transport of lutein by oral administration of a solid dispersion and a self-microemulsifying drug delivery system. SMEDDS
50  2018 HPMCAS as an effective precipitation inhibitor in amorphous solid dispersions of the poorly soluble drug candesartan cilexetil. CC, HPMC, HPMCAS
51  2018 Identification of molecular-interaction sites between lowly hydrolyzed polyvinyl alcohols and indomethacin by NMR spectroscopy. IND, NOESY, PVAs
52  2018 Molecular-level elucidation of saccharin-assisted rapid dissolution and high supersaturation level of drug from Eudragit E solid dispersion. EUD-E, PHT, SAC
53  2018 Preparation and comparison of tacrolimus-loaded solid dispersion and self-microemulsifying drug delivery system by in vitro/in vivo evaluation. HPMC, SMEDDS
54  2018 Preparation of curcumin self-micelle solid dispersion with enhanced bioavailability and cytotoxic activity by mechanochemistry. CUR
55  2018 Preparation of lapatinib ditosylate solid dispersions using solvent rotary evaporation and hot melt extrusion for solubility and dissolution enhancement. DSC, DT, HME, LB, PXRD, SEM, SRE
56  2018 Preparation, characterization and in vitro and in vivo evaluation of a solid dispersion of Naringin. FT-IR, NA
57  2018 Solid dispersion of dutasteride using the solvent evaporation method: Approaches to improve dissolution rate and oral bioavailability in rats. ATR FT-IR, BA, DSC, DUT, FESEM, MCC, PXRD, SLS, TPGS
58  2018 Solid dispersions to enhance the delivery of a potential drug candidate LPSF/FZ4 for the treatment of schistosomiasis. ---
59  2018 Synchronized release of bufadienolides in a stable Lutrol F127 based solid dispersion prepared with spray congealing. ---
60  2017 Bioenhanced advanced third generation solid dispersion of tadalafil: Repurposing with improved therapy in pyelonephritis. PN, SMEC, TDL
61  2017 Design of fixed dose combination and physicochemical characterization of enteric-coated bilayer tablet with circadian rhythmic variations containing telmisartan and pravastatin sodium. FDC, MgO, PEG 6000, PRA, TEL
62  2017 Design of PVP/VA S-630 based tadalafil solid dispersion to enhance the dissolution rate. BCS, DW, FT-IR, SLS, TDF
63  2017 Design, Optimization and Evaluation of Orally Disintegrating Tablet of Meloxicam Using Its Menthol Based Solid Dispersions. DSC, MLX, ODTs, PVP k30, SLS, XRD
64  2017 Development of a binary carrier system consisting polyethylene glycol 4000 - ethyl cellulose for ibuprofen solid dispersion. API, ATR-FTIR, DSC, EC, PEG, SDP, SEM
65  2017 Development, Physicochemical Characterization and In Vitro Anti-Inflammatory Activity of Solid Dispersions of alpha,beta Amyrin Isolated from Protium Oilresin. ABAM, DSC, FTIR, HPMC, KND, PM, RE, SEM, TG, XRD
66  2017 Enhancement of solubility and dissolution rate of baicalein, wogonin and oroxylin A extracted from Radix scutellariae. VC
67  2017 Enhancement of the aqueous solubility and permeability of a poorly water soluble drug ritonavir via lyophilized milk-based solid dispersions. DSC, FTIR, PXRD, RTV, SEM
68  2017 Ginger Extract-Loaded Solid Dispersion System with Enhanced Oral Absorption and Antihypothermic Action. GE, GE
69  2017 Improved Dissolution of Dipyridamole with the Combination of pH-Modifier and Solid Dispersion Technology. DP, TA
70  2017 Polymeric behavior evaluation of PVP K30-poloxamer binary carrier for solid dispersed nisoldipine by experimental design. SDnisol
71  2017 Role of P-Glycoprotein Inhibitors in the Bioavailability Enhancement of Solid Dispersion of Darunavir. DoE, DRV
72  2017 Surface Solid Dispersion and Solid Dispersion of Meloxicam: Comparison and Product Development. CPV, MLX, SSD
73  2017 Tadalafil solid dispersion formulations based on PVP/VA S-630: Improving oral bioavailability in rats. BA, TDF
74  2016 A comparative study on the effects of amphiphilic and hydrophilic polymers on the release profiles of a poorly water-soluble drug. DL, FEN, PF127
75  2016 A silica-supported solid dispersion of bifendate using supercritical carbon dioxide method with enhanced dissolution rate and oral bioavailability. DSC, RH, XRD
76  2016 Application of hot-melt extrusion technology for designing an elementary osmotic pump system combined with solid dispersion for a novel poorly water-soluble antidepressant. EOP, HME
77  2016 Atorvastatin solid dispersion for bioavailability enhancement. AT
78  2016 Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying. ATR-FTIR, DSC, ITZ, PXRD
79  2016 Chitosan-based nano-in-microparticle carriers for enhanced oral delivery and anticancer activity of propolis. CS, NIMs, NPs
80  2016 Development and evaluation of solid dispersion of spironolactone using fusion method. API, PEG 4000, SPL
81  2016 Development and Optimization of Controlled Porosity Osmotic Tablets of Lamotrigine Solid Dispersion. CPOT
82  2016 Dissolution enhancement of felodipine by amorphous nanodispersions using an amphiphilic polymer: insight into the role of drug-polymer interactions on drug dissolution. ---
83  2016 Enhancement of Dissolution Rate and Intestinal Stability of Clopidogrel Hydrogen Sulfate. ---
84  2016 Evaluation of physicochemical properties and in vivo efficiency of atorvastatin calcium/ezetimibe solid dispersions. ATV, DSC, EZT, PMs, PXRD, TC
85  2016 Extruded Soluplus/SIM as an oral delivery system: characterization, interactions, in vitro and in vivo evaluations. HME, PMs, SIM
86  2016 Formulation of cyclodextrin inclusion complex-based orally disintegrating tablet of eslicarbazepine acetate for improved oral bioavailability. beta-CD, DSC, ESL, FTIR, ODT, XRD
87  2016 Hydrophilic-hydrophobic polymer blend for modulation of crystalline changes and molecular interactions in solid dispersion. ---
88  2016 Improved oral absorption of tacrolimus by a solid dispersion with hypromellose and sodium lauryl sulfate. HPMC, SLS
89  2016 Investigation of Polymer-Surfactant and Polymer-Drug-Surfactant Miscibility for Solid Dispersion. ---
90  2016 Optimized sildenafil citrate fast orodissolvable film: a promising formula for overcoming the barriers hindering erectile dysfunction treatment. ODF
91  2016 Physical characterization and dissolution performance assessment of Etravirine solid dispersions prepared by spray drying process. ANOVA, DSC, FTIR, MDT, SEM
92  2016 Preparation and characterization of dipyridamole solid dispersions for stabilization of supersaturation: effect of precipitation inhibitors type and molecular weight. DPL, HPMC, PVP
93  2016 Sodium alginate as a potential carrier in solid dispersion formulations to enhance dissolution rate and apparent water solubility of BCS II drugs. SA, TEL
94  2016 Solid-state characterization of Felodipine-Soluplus amorphous solid dispersions. FEL, SOL
95  2016 Solubilization and formulation of chrysosplenol C in solid dispersion with hydrophilic carriers. CRSP, DSC, FTIR, SEM, SLS, XRD
96  2016 The improved dissolution performance of a post processing treated spray-dried crystalline solid dispersion of poorly soluble drugs. PVA
97  2015 A (polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer)-dispersed sustained-release tablet for imperialine to simultaneously prolong the drug release and improve the oral bioavailability. ---
98  2015 Anomalous role change of tertiary amino and ester groups as hydrogen acceptors in eudragit E based solid dispersion depending on the concentration of naproxen. EGE, NAP, Tg
99  2015 Controlled porosity solubility modulated osmotic pump tablets of gliclazide. CPOP, GLZ, HME
100  2015 Conversion of solid dispersion prepared by acid-base interaction into free-flowing and tabletable powder by using Neusilin US2. ---